HyperPack: A software package for the study of levels, contexts, and patterns of APOBEC-mediated hypermutation in HIV

被引:9
作者
Kijak, Gustavo H.
Janini, Mario
Tovanabutra, Sodsai
Sanders-Buell, Eric E.
Birx, Debora L.
Robb, Merlin L.
Michael, Nelson L.
McCutchan, Francine E.
机构
[1] Henry M Jackson Fdn Advancement Mil Med, US Mil HIV Res Program, Rockville, MD 20850 USA
[2] Walter Reed Army Med Ctr, Div Retrovirol, Rockville, MD 20850 USA
关键词
D O I
10.1089/aid.2006.0279
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
G-to-A hypermutation, a massive substitution of G for A, was first observed in HIV genomes 15 years ago. Initially ascribed to fluctuating nucleotide pools or PCR errors, it has now been recognized as the result of an important host-defense mechanism mediated by APOBECs, a family of sequence-specific cytidine deaminases. Levels of hypermutation vary, and APOBECs have different preferences for the sequence context of cytidines targeted for deamination; analysis of hypermutation provides important information about the host-virus interaction during viral replication. Here we present HyperPack, a software package to support systematic characterization of hypermutated sequences. Users can define the context of substitution for independent study of the effects of different APOBECs. The SubstrateScan and HyperScan modules are overlapping sliding-window strategies to analyze the distribution of targeted motifs and their substitution levels, respectively, across the viral genome. HyperPack is a platform-flexible, Java stand-alone application available through http://www.hivresearch.org/hyperpack/.
引用
收藏
页码:554 / 557
页数:4
相关论文
共 18 条
[1]   Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes:: Correlation with mutation spectra in vivo [J].
Beale, RCL ;
Petersen-Mahrt, SK ;
Watt, IN ;
Harris, RS ;
Rada, C ;
Neuberger, MS .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 337 (03) :585-596
[2]   Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America [J].
Carr, JK ;
Avila, M ;
Carrillo, MG ;
Salomon, H ;
Hierholzer, J ;
Watanaveeradej, V ;
Pando, MA ;
Negrete, M ;
Russell, KL ;
Sanchez, J ;
Birx, DL ;
Andrade, R ;
Vinoles, J ;
McCutchan, FE .
AIDS, 2001, 15 (15) :F41-F47
[3]   G->A hypermutation does not result from polymerase chain reaction [J].
Cheynier, R ;
Gratton, S ;
Vartanian, JP ;
Meyerhans, A ;
WainHobson, S .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (12) :985-986
[4]   A NEW-TYPE OF G-]A HYPERMUTATION AFFECTING HUMAN-IMMUNODEFICIENCY-VIRUS [J].
FITZGIBBON, JE ;
MAZAR, S ;
DUBIN, DT .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (09) :833-838
[5]   Retrovirus restriction factors [J].
Goff, SP .
MOLECULAR CELL, 2004, 16 (06) :849-859
[6]   Retroviral restriction by APOBEC proteins [J].
Harris, RS ;
Liddament, MT .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (11) :868-877
[7]   Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4+ T cells [J].
Janini, M ;
Rogers, M ;
Birx, DR ;
McCutchan, FE .
JOURNAL OF VIROLOGY, 2001, 75 (17) :7973-7986
[8]  
JANINI M, 2001, AIDS VACCINE 2001
[9]  
KIJAK GH, 2006, 13 INT WORKSH HIV DY
[10]   Hypermutation of HIV-1 DNA in the absence of the Vif protein [J].
Lecossier, D ;
Bouchonnet, F ;
Clavel, F ;
Hance, AJ .
SCIENCE, 2003, 300 (5622) :1112-1112